Position in LLY
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$293,860
+$93,351 QoQ
Shares Held
245
+12.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#4,172
of 4,605 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LCM Capital Management Inc holds $6,711,620 across 8 Drug Manufacturers - General names. LLY ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,695 | $2,716,209 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
8,991 | $1,135,922 | |
| 3 | AMRN |
Amarin Corp Plc\Uk
|
51,362 | $818,710 | |
| 4 | NVS |
Novartis AG
|
3,341 | $523,601 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,930 | $514,546 | |
| 6 | AMGN |
Amgen Inc
|
997 | $361,033 | |
| 7 | PFE |
Pfizer Inc
|
14,441 | $347,739 | |
| 8 | LLY |
ELI LILLY & Co
This page
|
245 | $293,860 |
All Filings in LLY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $293,860 | 245 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $200,509 | 218 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $223,533 | 208 | Shares | Sole | 2026-01-29 | |
| 2025-06-30 | $349,229 | 448 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $369,181 | 447 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $321,924 | 417 | Shares | Sole | 2025-01-27 | |
| No filing history on record for this holder in this stock. | ||||||